IRVINE, CA – Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the Edwards SAPIEN XT valve, making it the country's first commercially available transcatheter aortic heart valve.<br />
<br />
The company expects to obtain reimbursement approval from MHLW by year's end, and will initiate a full launch in Japan immediately ...This story is related to the following:Medical Valves |